Jones Day's prodigious client base spans major pharma companies, leading research institutes, key medical technology and device manufacturers, and investors. Cristiana Spontoni, who acts as co-head of the firm's healthcare and life sciences practice, handles work ranging from the pre-market phase, including clinical trials, to post-market issues, including product liability, marketing, distribution, and compliance. Mandates in the digital health space have been keeping the group particularly busy in recent times.

Legal 500 Editorial commentary

Key clients

  • Arsenal Capital
  • Astellas Pharma Inc.
  • BioMarin Pharmaceutical Inc.
  • Cellectis SA
  • Institut Pasteur
  • International PNH Interest Group
  • Lipton Teas and Infusions
  • MedTech Europe
  • Pharmaceutical Product Development
  • Shiseido
  • Sumitomo Dainippon Pharma

Work highlights

  • Advising BioMarin, a major developer of innovative biopharmaceuticals for rare diseases driven by genetic causes, on a wide array of regulatory issues.
  • Advising Sumitomo Dainippon Pharma on a wide variety of ongoing regulatory matters on a pan-European and global basis.
  • Advising Institut Pasteur on an array of EU-wide and global regulatory matters.

Lawyers

Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

The lawyer(s) leading their teams.

Cristiana Spontoni

Other key lawyers

Preslava Dilkova